Federal Appeals Court Rejects Hearing On Cox-2 Patent

Law360, New York (July 6, 2004, 12:00 AM EDT) -- The U.S. Court of Appeals for the Federal Circuit has denied the University of Rochester’s request for a hearing by the court’s full panel on the validity of a patent for cox-2 inhibitors such as Pfizer’s $3 billion Celebrex drug.

University of Rochester scientists claim they discovered the gene that produces the cox-2 enzyme and described the role it plays in producing inflammation and pain. Cox-2 inhibitors are drugs that can relieve pain and inflammation without causing cramps and bleeding.

The university applied for the patent...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.